Immediate Impact
2 by Nobel laureates 4 from Science/Nature 76 standout
Citing Papers
Phase 2 Trial of Baxdrostat for Treatment-Resistant Hypertension
2022 Standout
Treatment of Hypertension
2022 Standout
Works of Brian Gallay being referenced
Screening for primary aldosteronism without discontinuing hypertensive medications: Plasma aldosterone-renin ratio
2001
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Brian Gallay | 142 | 44 | 270 | 212 | 21 | 574 | |
| R Cipriani | 115 | 81 | 232 | 46 | 29 | 511 | |
| Wiguno Prodjosudjadi | 54 | 27 | 93 | 50 | 19 | 644 | |
| Eduardo Hernández | 53 | 91 | 136 | 49 | 25 | 527 | |
| Rosalía Valero | 251 | 45 | 154 | 51 | 41 | 463 | |
| Abanti Chaudhuri | 158 | 70 | 116 | 27 | 34 | 479 | |
| Robert J. Cunningham | 152 | 131 | 124 | 29 | 34 | 568 | |
| B. M. Saker | 44 | 33 | 122 | 27 | 26 | 583 | |
| Inge B. Brekke | 312 | 130 | 294 | 29 | 21 | 536 | |
| Clifford D. Miles | 298 | 82 | 239 | 65 | 30 | 536 | |
| Venkateswara Rao | 190 | 53 | 202 | 13 | 16 | 491 |
All Works
Loading papers...